ClinicalTrialsFinder

Relapsed/Refractory B-cell Lymphoma Clinical Trials in Shenzhen, Other (Non U.s.)

1 recruitingShenzhen, Other (Non U.s.), China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma

Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital20 enrolled1 locationNCT07097207